| Literature DB >> 33772113 |
Scott K Herrod1, Alex Stevenson2, Yvonne E Vaucher3, Scott R Lambert4, Sherwin J Isenberg5, Vivien L Yap6, V Chinyere Ezeaka7, Waldemar A Carlo8.
Abstract
OBJECTIVES: To provide more comprehensive data on the management of oxygen supplementation in neonates in sub-Saharan Africa. STUDYEntities:
Mesh:
Substances:
Year: 2021 PMID: 33772113 PMCID: PMC7995672 DOI: 10.1038/s41372-021-01040-7
Source DB: PubMed Journal: J Perinatol ISSN: 0743-8346 Impact factor: 2.521
Fig. 1Neonatal care units in sub-Saharan Africa who responded to our survey.
Some neonatal care units were in close proximity to each other and the individual points may not be distinguished from one another.
Neonatal care units with or without neonatologist.
| With a neonatologist | Without a neonatologist | |||
|---|---|---|---|---|
| Number of units | 47 | 35 | ||
| Number of countries | 20 | 17 | ||
| Admissions in 2019, median (min, max) | 1322 (70, 8000), ( | 779 (50, 3500), ( | NSa,b | |
| Daily census | NSa,c | |||
| 1–20 infants, | 15/43 (35%) | 19/34 (56%) | ||
| 21–50 infants, | 18/43 (42%) | 12/34 (35%) | ||
| ≥51 infants, | 10/43 (23%) | 3/34 (9%) | ||
| Bed capacity, median (min max) | 40 (7, 185), ( | 24 (3, 70), ( | NSa,b | |
| Bed type | ||||
| Radiant warmers, median (min, max) | 6 (0, 50), ( | 3 (0, 10), ( | ||
| Incubators, median (min, max) | 10 (0, 125), ( | 4 (0, 24), ( | ||
| Cots, median (min, max) | 22 (0, 120), ( | 10 (0, 68), ( | ||
| Number of nurses | ||||
| Day, median (min, max) | 8 (1, 50), ( | 4 (1, 10), ( | ||
| Night, median (min, max) | 4 (1, 33), ( | 2 (1, 8), ( | ||
aNot significant, (p value > 0.0009), based on Bonferroni Correction.
bp value calculated with Wilcoxon signed rank-sum test.
cp value calculated with Chi-squared (χ2) test.
Respiratory support in neonatal care units with and without neonatologist.
| With a neonatologist | Without a neonatologist | |||
|---|---|---|---|---|
| Infants on oxygen per day | NSa,b | |||
| 1–15, | 28/43 (65%) | 27/34 (79%) | ||
| ≥16, | 15/43 (35%) | 7/34 (21%) | ||
| Oxygen source | ||||
| In-wall oxygen lines, | 34/47 (72%) | 14/35 (40%) | NSa,b | |
| Oxygen cylinders, | 29/47 (62%) | 25/35 (71%) | NSa,b | |
| Oxygen concentrator, | 29/47 (62%) | 25/35 (71%) | NSa,b | |
| Oxygen unavailable, | 0/47 (0%) | 0/35 (0%) | NAc | |
| Air source | ||||
| In-wall air lines, | 20/44 (45%) | 7/32 (22%) | NSa,b | |
| Air compressor, | 8/44 (18%) | 5/32 (16%) | NSa,b | |
| Medical air unavailable, | 19/44 (43%) | 21/32 (66%) | NSa,b | |
| Air/oxygen blending method | ||||
| Wall blender, | 9/44 (20%) | 3/32 (9%) | NSa,b | |
| Integrated into CPAPd/Ventilator, | 24/44 (55%) | 8/32 (25%) | NSa,b | |
| Venturi, | 1/44 (2%) | 0/32 (0%) | NSa,b | |
| Unable to blend, | 17/44 (39%) | 21/32 (66%) | NSa,b | |
| Number wall blenders per unit, median (min, max) | 0 (0, 40), ( | 0 (0, 16), ( | NSa,e | |
| Percentage infants on oxygen who receive blended air/oxygen | ||||
| 0%, | 19/41 (46%) | 23/34 (68%) | NSa,b | |
| 100%, | 1/41 (2%) | 0/34 (0%) | NSa,b | |
| Oxygen administration method | ||||
| Headbox, | 11/47 (23%) | 3/35 (9%) | NSa,b | |
| LFf nasal cannula, | 43/47 (91%) | 32/35 (91%) | NSa,b | |
| HFg nasal cannula, | 18/47 (38%) | 14/35 (40%) | NSa,b | |
| CPAPd, | 41/47 (87%) | 21/35 (60%) | NSa,b | |
| Ventilator, | 19/47 (40%) | 3/35 (9%) | NSa,b | |
| Incubator oxygen, | 1/47 (2%) | 0/35 (0%) | NSa,b | |
| Equipment available | ||||
| Headbox, median (min, max) | 0 (0, 20), ( | 0 (0, 16), ( | NSa,e | |
| LFf nasal cannula, median (min, max) | 15 (2, 100), ( | 5 (0, 50), ( | NSa,e | |
| HFg nasal cannula, median (min, max) | 3 (0, 15), ( | 1 (0, 30), ( | NSa,e | |
| RAM cannula, median (min, max) | 0 (0, 10), ( | 0 (0, 16), ( | NSa,e | |
| Vapotherm, median (min, max) | 0 (0, 5), ( | 0 (0, 2), ( | NSa,e | |
| CPAPd, median (min, max) | 4 (0, 50), ( | 2 (0, 10), ( | NSa,e | |
| Ventilator, median (min, max) | 2 (0, 31), ( | 0 (0, 4), ( | NSa,e | |
| Humidification system | NSa,b | |||
| No, | 16/41 (39%) | 15/23 (65%) | ||
| Percentage infants receiving humidified air/oxygen | ||||
| 0%, | 13/39 (33%) | 14/23 (61%) | NSa,b | |
| 100%, | 4/39 (10%) | 1/23 (4%) | NSa,b | |
aNot significant, (p value > 0.0009), based on Bonferroni Correction.
bp value calculated with Chi-squared (χ2) test.
cNot applicable.
dContinuous positive airway pressure.
ep value calculated with Wilcoxon signed rank-sum test.
fLow-flow.
gHigh-flow.
Oxygen saturation monitoring in neonatal care units with and without neonatologist.
| With a neonatologist | Without a neonatologist | |||
|---|---|---|---|---|
| Oxygen management protocol | NSa,b | |||
| No, | 25/44 (57%) | 24/34 (71%) | ||
| Number of pulse oximeters, median (min, max) | 4 (0, 72), ( | 3 (0, 16), ( | NSa,c | |
| Saturation levels monitored | ||||
| 0%, | 1/41 (2%) | 2/34 (6%) | NSa,b | |
| 100%, | 12/41 (29%) | 12/34 (35%) | NSa,b | |
| Preterm infant monitoring | NSa,b | |||
| Continuous, | 11/45 (24%) | 10/34 (29%) | ||
| Intermittent, | 34/45 (76%) | 24/34 (71%) | ||
| Preterm infant alarm limits | NSa,b | |||
| Yes, | 21/26 (81%) | 14/19 (74%) | ||
| No, | 5/26 (19%) | 5/19 (26%) | ||
| Preterm saturation targets | ||||
| Lower, median (min, max) | 90 (70, 96), ( | 91 (70, 97), ( | NSa,c | |
| Upper, median (min, max) | 95 (80, 100), ( | 95 (85, 100), ( | NSa,c | |
| Preterm alarm limits | ||||
| Lower, median (min, max) | 88 (79, 91), ( | 89 (79, 90), ( | NSa,c | |
| Upper, median (min, max) | 96 (92, 100), ( | 100 (95, 100), ( | NSa,c | |
| Term infant monitoring | NSa,b | |||
| Continuous, | 5/46 (11%) | 6/33 (18%) | ||
| Intermittent, | 41/46 (89%) | 27/33 (82%) | ||
| Term infant alarm limits | NSa,b | |||
| Yes, | 23/29 (79%) | 15/22 (68%) | ||
| No, | 6/29 (21%) | 7/22 (32%) | ||
| Term saturation targets | ||||
| Lower, median (min, max) | 91 (85, 96), ( | 91 (70, 96), ( | NSa,c | |
| Upper, median (min, max) | 96 (90, 100), ( | 100 (89, 100), ( | NSa,c | |
| Term alarm limits | ||||
| Lower, median (min, max) | 89 (69, 94), ( | 89 (79, 95), ( | NSa,c | |
| Upper, median (min, max) | 97 (91, 100), ( | 100 (96, 100), ( | NSa,c | |
aNot significant, (p value > 0.0009), based on Bonferroni Correction.
bp value calculated with Chi-squared (χ2) test.
cp value calculated with Wilcoxon signed rank-sum test.